BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Covis Announces Successful Completion of Its Previously Announced Financial Recapitalization Transaction, Resulting in a Material Strengthening of Its Financial Position

  Covis Finco Sarl, announced the closing of its financial recapitalization transaction per the previously announced Support Agreement entered into with its Equity Sponsors, 100% of its First Lien Lenders and 100% of its Second Lien Lenders.

  June 1, 2023

   · 

  2 min read
• Medigene Announces Pipeline Expansion into Neoantigens with Programs Targeting Multiple KRAS Mutations and HLAs

  Medigene AG announces its pipeline expansion into neoantigens with KRAS as the first target in its MDG10xx program, a T cell receptor engineered T cell therapy being developed in combination with the company’s PD1-41BB switch receptor technology.

  June 1, 2023

   · 

  6 min read
• Genetown

  Invivyd to Participate at the 2023 Jefferies Healthcare Conference

  Invivyd, Inc. announced that David Hering, chief executive officer of Invivyd, is scheduled to present at the Jefferies Healthcare Conference on Friday, June 9, 2023 at 11:30 a.m. ET in New York, NY.

  June 1, 2023

   · 

  1 min read
• Genetown

  Omega Therapeutics to Participate in Two Upcoming June 2023 Investor Conferences

  Omega Therapeutics, Inc., a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines, announced that management will participate in two upcoming investor conferences.

  June 1, 2023

   · 

  1 min read
• Pharm Country

  Cara Therapeutics to Present at the 2023 Jefferies Healthcare Conference

  Cara Therapeutics, Inc. announced that Christopher Posner, President and Chief Executive Officer, will present at the Jefferies Healthcare Conference on Thursday, June 8, 2023, at 3 p.m. EDT in New York, NY.

  June 1, 2023

   · 

  1 min read
• Genetown

  Kymera Therapeutics to Participate in Upcoming June 2023 Investor Conference

  Kymera Therapeutics, Inc. announced that the Company’s management team will attend the following upcoming investor event:

  June 1, 2023

   · 

  1 min read
• ESSA Pharma to Present at 2023 Jefferies Healthcare Conference

  ESSA Pharma Inc. today announced that the Company will be presenting at the Jefferies Healthcare Conference on Thursday, June 8, 2023 at 8:00 a.m. Eastern Time in New York.

  June 1, 2023

   · 

  1 min read
• Biotech Beach

  Ionis announces positive donidalorsen late-stage clinical progress in HAE

  Ionis Pharmaceuticals, Inc . (Nasdaq: IONS) today announced positive clinical progress with donidalorsen, its late-stage investigational prophylactic therapy for hereditary angioedema (HAE).

  June 1, 2023

   · 

  5 min read
• BioCapital

  REGENXBIO Announces Presentation at the Jefferies Global Healthcare Conference

  REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will present and host one-on-one investor meetings at the Jefferies Global Healthcare Conference on Thursday, June 8, 2023.

  June 1, 2023

   · 

  1 min read
• Novocure Pledges $3 Million to Conquer Cancer®, the ASCO Foundation, to Support Cancer Research and Education

  Novocure Pledges $3 Million to Conquer Cancer ® , the ASCO Foundation, to Support Cancer Research and Education.

  June 1, 2023

   · 

  4 min read